Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...

At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to ...

An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

New research reveals a retinal light test may hold the key to detecting Parkinson's disease long before motor symptoms appear ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of ...

Steven J. Fliesler, PhD, SUNY Distinguished Professor and Meyer H. Riwchun Endowed Chair Professor of ophthalmology in the Jacobs School of Medicine and Biomedical Sciences, has received the 2025 ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Background Coronary artery disease (CAD) is linked to an increased risk of mild cognitive impairment (MCI). Effective and ...